Futura Medical (LON:FUM) Trading Up 9.1% – Still a Buy?

Shares of Futura Medical plc (LON:FUM) rose 9.1% during mid-day trading on Tuesday . The stock traded as high as GBX 0.68 and last traded at GBX 0.60. Approximately 869,398 shares were traded during trading, a decline of 86% from the average daily volume of 6,093,403 shares. The stock had previously closed at GBX 0.55.

Futura Medical Price Performance

The business has a 50 day moving average of GBX 0.88 and a 200 day moving average of GBX 1.10. The firm has a market capitalization of £3.49 million, a price-to-earnings ratio of -0.22 and a beta of 0.01.

Futura Medical (LON:FUM) last issued its quarterly earnings data on Wednesday, April 29th. The company reported GBX (2.78) earnings per share (EPS) for the quarter. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%.The company had revenue of GBX 170 million for the quarter. As a group, equities analysts predict that Futura Medical plc will post 2.8486672 EPS for the current year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.